Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Posted by: Jessie Scanlon on September 23, 2009
I didn’t know half of the words that Joseph Kim, the CEO & Director of Inovio Biomedical, used in his EmTech presentation but I walked away with a new appreciation for vaccines — present and future.
The gist: Vaccines have saved more lives than any other human invention. While the traditionally-developed vaccines used to guard against diseases such as polio and various poxes, have saved millions of lives and prevented suffering, there are significant shortcomings to the traditional vaccine-development approach. Inovio and others are developing DNA-based vaccines that are cheaper to manufacture, safer to give, and last longer, so that you wouldn’t have to get a new flu shot every year.
What comes next? The BusinessWeek Innovation and Design team of Michael Arndt and Helen Walters chronicle new tools for creativity and collaboration, innovation case studies in both the corporate and social sectors, and the new ideas that have the power to change the way things have always been done.